Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc.（LYRA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lyra · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年3月20日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Hold
5 位分析师
共识
评级分布
12 个月目标价
High
$0.50
Consensus
$0.50
-23.1% upside
Low
$0.50
Median: $0.5 · Last Close: $0.65
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.68 | ↑ 5.00% |
1-day model range: $0.67–$0.69. Peak: $0.69 (+5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LYRA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-06-10 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-05-07 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2024-05-07 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-05-06 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-05-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-25 | B of A Securities | Maintains | Buy→Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lyra Therapeutics, Inc. (LYRA) stock. Of the recent 16 rating actions, 0 were upgrades and 3 were downgrades. 5 analysts currently cover LYRA.
分析师推荐趋势
LYRA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 86.0% YoY
Revenue Next Year
$3M
↑ 237.5% YoY
EPS This Year
$-1.50
EPS Next Year
$-0.99
↓ 34.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast LYRA EPS of $-1.50 for the current fiscal year, based on estimates from 1 analysts. The LYRA revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LYRA 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LYRA 的共识目标价为 $0.50（-23.1% 上行空间），分析师共识为 Hold。
LYRA 的短期预测（明日）为 $0.68（+5.00%）。
Lyra Therapeutics, Inc. 在 NASDAQ 上市，代码 LYRA。LYRA 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 40% 对应 Hold 共识。
常见问题
LYRA 预测 · 8 个问题根据 5 位华尔街分析师，LYRA 的 12 个月平均目标价为 $0.50，最高 $0.50、最低 $0.50。若有图表，中位目标价可在上方查看。相对当前价 $0.65，隐含约 -23.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.